Reference Standards | Research Chemicals | Research Services


Palbociclib is a medication used for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.

Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy.

We offers Reference Standards, Impurity standards, Isotope Labelled Compounds & Metabolites

Enquire Now